Search Results - "Boyaka, PN"

Refine Results
  1. 1

    Effective Mucosal Immunity to Anthrax: Neutralizing Antibodies and Th Cell Responses Following Nasal Immunization with Protective Antigen by Boyaka, Prosper N, Tafaro, Angela, Fischer, Romy, Leppla, Stephen H, Fujihashi, Kohtaro, McGhee, Jerry R

    Published in The Journal of immunology (1950) (01-06-2003)
    “…Mucosal, but not parenteral, immunization induces immune responses in both systemic and secretory immune compartments. Thus, despite the reports that Abs to…”
    Get full text
    Journal Article
  2. 2

    The mode of oral bovine lactoferrin administration influences mucosal and systemic immune responses in mice by Sfeir, Rose Mary, Dubarry, Michel, Boyaka, Prosper N, Rautureau, Michèle, Tomé, Daniel

    Published in The Journal of nutrition (01-02-2004)
    “…Food protein intake interacts with the immune system. In earlier nutritional and immunological studies, nutrients, particularly milk whey proteins, were…”
    Get more information
    Journal Article
  3. 3

    Bacillus anthracis Edema Toxin Acts as an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens by Duverger, Alexandra, Jackson, Raymond J, van Ginkel, Frederick W, Fischer, Romy, Tafaro, Angela, Leppla, Stephen H, Fujihashi, Kohtaro, Kiyono, Hiroshi, McGhee, Jerry R, Boyaka, Prosper N

    Published in Journal of Immunology (01-02-2006)
    “…Anthrax edema toxin (EdTx) is an AB-type toxin that binds to anthrax toxin receptors on target cells via the binding subunit, protective Ag (PA). Edema factor,…”
    Get full text
    Journal Article
  4. 4

    Mechanisms for Induction of Acquired Host Immunity by Neutrophil Peptide Defensins by Lillard, James W., Boyaka, Prosper N., Chertov, Oleg, Oppenheim, Joost J., McGhee, Jerry R.

    “…Human neutrophil peptide (HNP) defensins were studied to determine their potential effects on adaptive mucosal immunity. Intranasal delivery of HNPs plus…”
    Get full text
    Journal Article
  5. 5

    In situ gastrointestinal protection against anthrax edema toxin by single-chain antibody fragment producing lactobacilli by Andersen, Kasper Krogh, Marcotte, Harold, Álvarez, Beatriz, Boyaka, Prosper N, Hammarström, Lennart

    Published in BMC biotechnology (20-12-2011)
    “…Anthrax is caused by the bacterium Bacillus anthracis and is regarded as one of the most prominent bioterrorism threats. Anthrax toxicity is induced by the…”
    Get full text
    Journal Article
  6. 6

    MIP-1α and MIP-1β differentially mediate mucosal and systemic adaptive immunity by Lillard, James W., Singh, Udai P., Boyaka, Prosper N., Singh, Shailesh, Taub, Dennis D., McGhee, Jerry R.

    Published in Blood (01-02-2003)
    “…Macrophage inflammatory protein-1α (MIP-1α) and MIP-1β are distinct but highly homologous CC chemokines produced by a variety of host cells in response to…”
    Get full text
    Journal Article
  7. 7

    Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4 by Marinaro, M, Staats, HF, Hiroi, T, Jackson, RJ, Coste, M, Boyaka, PN, Okahashi, N, Yamamoto, M, Kiyono, H, Bluethmann, H

    Published in The Journal of immunology (1950) (15-11-1995)
    “…Despite pathophysiologic effects including diarrhea, cholera toxin (CT) is a potent mucosal immunogen and adjuvant. We investigated the influence of CT on T…”
    Get full text
    Journal Article
  8. 8

    Oral and Nasal Sensitization Promote Distinct Immune Responses and Lung Reactivity in a Mouse Model of Peanut Allergy by Fischer, Romy, McGhee, Jerry R., Vu, Huong Lan, Atkinson, T. Prescott, Jackson, Raymond J., Tomé, Daniel, Boyaka, Prosper N.

    Published in The American journal of pathology (01-12-2005)
    “…Despite structural and functional differences between the initial sites of contact with allergens in the gastrointestinal and nasal tracts, few animal models…”
    Get full text
    Journal Article
  9. 9

    RANTES Potentiates Antigen-Specific Mucosal Immune Responses by Lillard, James W., Jr, Boyaka, Prosper N, Taub, Dennis D, McGhee, Jerry R

    Published in The Journal of immunology (1950) (01-01-2001)
    “…RANTES is produced by lymphoid and epithelial cells of the mucosa in response to various external stimuli and is chemotactic for lymphocytes. The role of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    IL-12 Is an Effective Adjuvant for Induction of Mucosal Immunity by Boyaka, Prosper N, Marinaro, Mariarosaria, Jackson, Raymond J, Menon, Satish, Kiyono, Hiroshi, Jirillo, Emilio, McGhee, Jerry R

    Published in The Journal of immunology (1950) (01-01-1999)
    “…We addressed the effects of two cytokines, IL-6 and IL-12, derived from APCs, for the development of mucosal IgA Ab responses following their nasal delivery…”
    Get full text
    Journal Article
  12. 12

    Chimeras of Labile Toxin One and Cholera Toxin Retain Mucosal Adjuvanticity and Direct Th Cell Subsets Via Their B Subunit by Boyaka, Prosper N, Ohmura, Mari, Fujihashi, Kohtaro, Koga, Toshiya, Yamamoto, Masafumi, Kweon, Mi-Na, Takeda, Yoshifumi, Jackson, Raymond J, Kiyono, Hiroshi, Yuki, Yoshikazu, McGhee, Jerry R

    Published in The Journal of immunology (1950) (01-01-2003)
    “…Native cholera toxin (nCT) and the heat-labile toxin 1 (nLT) of enterotoxigenic Escherichia coli are AB5-type enterotoxins. Both nCT and nLT are effective…”
    Get full text
    Journal Article
  13. 13

    Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses by Marinaro, M, Boyaka, P N, Finkelman, F D, Kiyono, H, Jackson, R J, Jirillo, E, McGhee, J R

    Published in The Journal of experimental medicine (03-02-1997)
    “…Our past studies have shown that the mucosal adjuvant cholera toxin (CT) induces T helper type 2 (Th2) responses with systemic IgG1, IgE and mucosal secretory…”
    Get full text
    Journal Article
  14. 14

    Peanut-lupine antibody cross-reactivity is not associated to cross-allergenicity in peanut-sensitized mouse strains by Lifrani, Awatif, Dubarry, Michel, Rautureau, Michèle, Aattouri, Najat, Boyaka, Prosper N., Tomé, Daniel

    Published in International immunopharmacology (01-08-2005)
    “…Peanut hypersensitivity is one of the most common food allergies and one of the most common causes of death by food anaphylaxis in children and adults…”
    Get full text
    Journal Article
  15. 15

    Therapeutic manipulation of the immune system: enhancement of innate and adaptive mucosal immunity by Boyaka, Prosper N, Tafaro, Angela, Fischer, Romy, Fujihashi, Kohtaro, Jirillo, Emilio, McGhee, Jerry R

    Published in Current pharmaceutical design (01-01-2003)
    “…The mucosal immune system has evolved alongside, but separate, from the general systemic immune system. As a major consequence of this dichotomy, only immune…”
    Get more information
    Journal Article
  16. 16

    Oral QS-21 Requires Early IL-4 Help for Induction of Mucosal and Systemic Immunity by Boyaka, Prosper N, Marinaro, Mariarosaria, Jackson, Raymond J, van Ginkel, Frederik W, Cormet-Boyaka, Estelle, Kirk, Kevin L, Kensil, Charlotte R, McGhee, Jerry R

    Published in The Journal of immunology (1950) (15-02-2001)
    “…The highly purified saponin derivative, QS-21, from the Quillaja saponaria Molina tree has been proved to be safe for parenteral administration and represents…”
    Get full text
    Journal Article
  17. 17

    Use of Intranasal IL-12 to Target Predominantly Th1 Responses to Nasal and Th2 Responses to Oral Vaccines Given with Cholera Toxin by Marinaro, Mariarosaria, Boyaka, Prosper N, Jackson, Raymond J, Finkelman, Fred D, Kiyono, Hiroshi, Jirillo, Emilio, McGhee, Jerry R

    Published in The Journal of immunology (1950) (01-01-1999)
    “…We have investigated the effects of IL-12 and cholera toxin (CT) on the immune response to tetanus toxoid (TT) given by intranasal or oral routes. CT inhibited…”
    Get full text
    Journal Article
  18. 18

    Syntaxin 1A is expressed in airway epithelial cells, where it modulates CFTR Cl(-) currents by Naren, A P, Di, A, Cormet-Boyaka, E, Boyaka, P N, McGhee, J R, Zhou, W, Akagawa, K, Fujiwara, T, Thome, U, Engelhardt, J F, Nelson, D J, Kirk, K L

    Published in The Journal of clinical investigation (01-02-2000)
    “…The CFTR Cl(-) channel controls salt and water transport across epithelial tissues. Previously, we showed that CFTR-mediated Cl(-) currents in the Xenopus…”
    Get full text
    Journal Article
  19. 19

    Lymphotactin Acts as an Innate Mucosal Adjuvant by Lillard, James W., Jr, Boyaka, Prosper N, Hedrick, Joseph A, Zlotnik, Albert, McGhee, Jerry R

    Published in The Journal of immunology (1950) (15-02-1999)
    “…Lymphotactin (Lptn) is a C chemokine produced predominantly by NK and CD8-positive (CD8+) T cells including gammadelta TCR-positive (TCR+) intraepithelial…”
    Get full text
    Journal Article
  20. 20

    Cytokines as adjuvants for the induction of mucosal immunity by Boyaka, Prosper N., McGhee, Jerry R.

    Published in Advanced drug delivery reviews (23-09-2001)
    “…Safe nasal vaccines capable of promoting both mucosal and systemic immunity are needed for effective protection against bacterial and viral pathogens. While…”
    Get full text
    Journal Article